Get your free personalized podcast brief

We scan new podcasts and send you the top 5 insights daily.

Dr. Florence Comette, a precision medicine doctor, used an Apple Watch and a continuous glucose monitor to discover her own health problem. She found that her inadequate deep sleep was triggering wild swings in blood glucose, causing unhealthy cravings and putting her at risk for diabetes.

Related Insights

The utility of collecting personal health data from wearables (like a WHOOP band) is not static; it compounds over time as AI model intelligence increases. Data that yields minor insights today could unlock profound health predictions in the future, creating a new incentive for consumers to start gathering longitudinal data on themselves now, even if the immediate benefit seems marginal.

Recent FDA guidance distinguishes general wellness wearables from high-risk medical devices like pacemakers, giving companies like Oura more leeway for innovation. This aims to transform wearables into 'digital health screeners' that provide early disease warnings, encouraging earlier intervention and potentially lowering healthcare costs by changing behavior before chronic conditions escalate.

By integrating on-demand clinicians and blood panels into their apps, wearable companies like Whoop and Aura are spearheading a shift to consumer-led healthcare. Users are bypassing traditional systems, demanding doctors who can interpret their personal health data, and creating a new healthcare stack from the ground up.

Broad diagnostic categories like 'diabetes' or 'insomnia' likely encompass several distinct underlying conditions. Continuous data streams from wearables and CGMs can help researchers identify these subtypes, paving the way for more personalized treatments.

The company's core value proposition is not just collecting new biochemical data, but fusing it with existing data streams from consumer wearables (like Apple Watch, Oura) and EMRs. This combination creates an exponentially more valuable, holistic view of a person's health that is currently impossible to achieve.

On-body glucose monitors give oncologists a richer understanding of a patient's glucose control, including 24-hour trends, time-in-range, and an A1c equivalent (GMI). This real-time data is critical for managing hyperglycemia from targeted therapies, offering more insight than periodic fasting tests.

The goal of advanced in-home health tech is not just to track vitals but to use AI to analyze subtle changes, like gait. By comparing data to population norms and personal baselines, these systems can predict issues and enable early, less invasive interventions before a crisis occurs.

By feeding an AI agent diverse personal data—diet logs, sleep tracking, bloodwork, and genetics—it can identify complex health issues that elude general advice. The AI can find "needle in the haystack" answers, like connecting restless leg syndrome to Swedish ancestry, offering hyper-personalized insights.

Current wearables passively track sleep. The next generation of technology will actively induce and manage sleep by 'writing' to our biology—for example, using devices that directly cool the body's core through the palms or eye masks that guide eye movements to accelerate sleep onset.

For select patients who find frequent lab checks for hyperglycemia monitoring to be a significant barrier, a continuous glucose monitor (CGM) can be a practical alternative. While off-label, it provides valuable data for management in patients who might otherwise be non-adherent with monitoring.

Consumer Wearables Can Uncover Root Causes of Health Issues That Doctors Miss | RiffOn